Norman Fields Gottscho Capital Management LLC Cuts Position in Agilent Technologies, Inc. (NYSE:A)

Norman Fields Gottscho Capital Management LLC decreased its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 4.2% in the 1st quarter, HoldingsChannel reports. The fund owned 37,880 shares of the medical research company’s stock after selling 1,670 shares during the quarter. Agilent Technologies comprises about 2.1% of Norman Fields Gottscho Capital Management LLC’s investment portfolio, making the stock its 14th biggest holding. Norman Fields Gottscho Capital Management LLC’s holdings in Agilent Technologies were worth $5,512,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies during the fourth quarter valued at $26,000. MV Capital Management Inc. boosted its stake in shares of Agilent Technologies by 120.7% during the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after acquiring an additional 105 shares during the last quarter. VisionPoint Advisory Group LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter valued at $29,000. Baystate Wealth Management LLC boosted its stake in shares of Agilent Technologies by 107.3% during the fourth quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock valued at $36,000 after acquiring an additional 133 shares during the last quarter. Finally, Rosenberg Matthew Hamilton lifted its position in Agilent Technologies by 51.1% during the fourth quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after buying an additional 96 shares during the period.

Agilent Technologies Stock Up 2.3 %

NYSE A traded up $3.07 during mid-day trading on Wednesday, reaching $134.90. 3,453,080 shares of the company’s stock traded hands, compared to its average volume of 2,188,750. The company has a market cap of $39.36 billion, a price-to-earnings ratio of 31.88, a P/E/G ratio of 4.47 and a beta of 1.07. The company has a fifty day simple moving average of $140.41 and a 200-day simple moving average of $138.28. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 0.34. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35.

Agilent Technologies (NYSE:AGet Free Report) last issued its earnings results on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.19 by $0.03. The company had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The business’s revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.27 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.25 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be given a dividend of $0.236 per share. The ex-dividend date is Tuesday, July 2nd. This represents a $0.94 dividend on an annualized basis and a yield of 0.70%. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on A shares. Barclays cut their price objective on Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating on the stock in a report on Friday, May 31st. Stifel Nicolaus cut their price objective on Agilent Technologies from $163.00 to $151.00 and set a “buy” rating on the stock in a report on Thursday, May 30th. Evercore ISI cut their price objective on Agilent Technologies from $145.00 to $126.00 and set an “in-line” rating on the stock in a report on Thursday, May 30th. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $135.00 price objective (down from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. One investment analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $136.50.

View Our Latest Stock Analysis on Agilent Technologies

Insider Activity at Agilent Technologies

In related news, SVP Philip Binns sold 2,827 shares of the business’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $147.54, for a total transaction of $417,095.58. Following the completion of the transaction, the senior vice president now owns 9,997 shares in the company, valued at approximately $1,474,957.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the sale, the senior vice president now owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Philip Binns sold 2,827 shares of Agilent Technologies stock in a transaction on Monday, March 25th. The shares were sold at an average price of $147.54, for a total value of $417,095.58. Following the sale, the senior vice president now directly owns 9,997 shares in the company, valued at approximately $1,474,957.38. The disclosure for this sale can be found here. Insiders sold 19,785 shares of company stock worth $2,670,836 in the last 90 days.

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.